Public health surveillance

Last updated

Public health surveillance (also epidemiological surveillance, clinical surveillance or syndromic surveillance) is, according to the World Health Organization (WHO), "the continuous, systematic collection, analysis and interpretation of health-related data needed for the planning, implementation, and evaluation of public health practice." [1] Public health surveillance may be used to track emerging health-related issues at an early stage and find active solutions in a timely manner. [1] Surveillance systems are generally called upon to provide information regarding when and where health problems are occurring and who is affected. [2]

Contents

Public Health surveillance systems can be passive or active. A passive surveillance system consists of the regular, ongoing reporting of diseases and conditions by all health facilities in a given territory. An active surveillance system is one where health facilities are visited and health care providers and medical records are reviewed in order to identify a specific disease or condition. [3] Passive surveillance systems are less time-consuming and less expensive to run but risk under-reporting of some diseases. Active surveillance systems are most appropriate for epidemics or where a disease has been targeted for elimination. [3]

Techniques of public health surveillance have been used in particular to study infectious diseases. Many large institutions, such as the WHO and the CDC, have created databases and modern computer systems (public health informatics) that can track and monitor emerging outbreaks of illnesses such as influenza, SARS, HIV, and even bioterrorism, such as the 2001 anthrax attacks in the United States.

Many regions and countries have their own cancer registry, one function of which is to monitor the incidence of cancers to determine the prevalence and possible causes of these illnesses.

Other illnesses such as one-time events like stroke and chronic conditions such as diabetes, as well as social problems such as domestic violence, are increasingly being integrated into epidemiologic databases called disease registries that are being used in the cost-benefit analysis in determining governmental funding for research and prevention.

Systems that can automate the process of identifying adverse drug events, are currently being used, and are being compared to traditional written reports of such events. [4] These systems intersect with the field of medical informatics, and are rapidly becoming adopted by hospitals and endorsed by institutions that oversee healthcare providers (such as JCAHO in the United States). Issues in regard to healthcare improvement are evolving around the surveillance of medication errors within institutions. [5]

Syndromic surveillance

Syndromic surveillance is the analysis of medical data to detect or anticipate disease outbreaks. According to a CDC definition, "the term 'syndromic surveillance' applies to surveillance using health-related data that precede diagnosis and signal a sufficient probability of a case or an outbreak to warrant further public health response. Though historically syndromic surveillance has been utilized to target investigation of potential cases, its utility for detecting outbreaks associated with bioterrorism is increasingly being explored by public health officials." [6]

The first indications of disease outbreak or bioterrorist attack may not be the definitive diagnosis of a physician or a lab. [7]

Using a normal influenza outbreak as an example, once the outbreak begins to affect the population, some people may call in sick for work/school, others may visit their drug store and purchase medicine over the counter, others will visit their doctor's office and other's may have symptoms severe enough that they call the emergency telephone number or go to an emergency department.

Syndromic surveillance systems monitor data from school absenteeism logs, emergency call systems, hospitals' over-the-counter drug sale records, Internet searches, and other data sources to detect unusual patterns. When a spike in activity is seen in any of the monitored systems disease epidemiologists and public health professionals are alerted that there may be an issue.

An early awareness and response to a bioterrorist attack could save many lives and potentially stop or slow the spread of the outbreak. The most effective syndromic surveillance systems automatically monitor these systems in real-time, do not require individuals to enter separate information (secondary data entry), include advanced analytical tools, aggregate data from multiple systems, across geo-political boundaries and include an automated alerting process. [8]

A syndromic surveillance system based on search queries was first proposed by Gunther Eysenbach, who began work on such a system in 2004. [9] Inspired by these early, encouraging experiences, Google launched Google Flu Trends [10] in 2008. More flu-related searches are taken to indicate higher flu activity. The results closely match CDC data, and lead it by 1–2 weeks. The results appeared in Nature. [11] More recently, a series of more advanced linear and nonlinear approaches to influenza modelling from Google search queries have been proposed. [12] Extending Google's work researchers from the Intelligent Systems Laboratory (University of Bristol, UK) created Flu Detector; [13] an online tool which based on Information Retrieval and Statistical Analysis methods uses the content of Twitter to nowcast flu rates in the UK. [14]

Influenzanet

Influenzanet is a syndromic surveillance system based on voluntary reports of symptoms via the internet. Residents of the participant countries are invited to provide regular reports on the presence or absence of flu related symptoms. The system has been in place and running since 2003 in the Netherlands and Belgium. The success of this first initiative led to the implementation of Gripenet in Portugal in 2005 followed by Italy in 2008 and Brasil, Mexico, and the United Kingdom in 2009.

Laboratory-based surveillance

Some conditions, especially chronic diseases such as diabetes mellitus, are supposed to be routinely managed with frequent laboratory measurements. Since many laboratory results, at least in Europe and the US, are automatically processed by computerized laboratory information systems, the results are relatively easy to inexpensively collate in special purpose databases or disease registries. Unlike most syndromic surveillance systems, in which each record is assumed to be independent of the others, laboratory data in chronic conditions can be theoretically linked together at the individual patient level. If patient identifiers can be matched, a chronological record of each patient's laboratory results can be analyzed as well as aggregated to the population level.

Laboratory registries allow for the analysis of the incidence and prevalence of the target condition as well as trends in the level of control. For instance, an NIH-funded program called the Vermedx Diabetes Information System [15] maintained a registry of laboratory values of diabetic adults in Vermont and northern New York State in the US with several years of laboratory results on thousands of patients. [16] The data included measures of blood sugar control (glycosolated hemoglobin A1C), cholesterol, and kidney function (serum creatinine and urine protein), and were used to monitor the quality of care at the patient, practice, and population levels. Since the data contained each patient's name and address, the system was also used to communicate directly with patients when the laboratory data indicated the need for attention. Out of control test results generated a letter to the patient suggesting they take action with their medical provider. Tests that were overdue generated reminders to have testing performed. The system also generated reminders and alerts with guideline-based advice for the practice as well as a periodic roster of each provider's patients and a report card summarizing the health status of the population. Clinical and economic evaluations of the system, including a large randomized clinical trial, demonstrated improvements in adherence to practice guidelines and reductions in the need for emergency department and hospital services as well as total costs per patient. [17] [18] [19] The system has been commercialized and distributed to physicians, insurers, employers and others responsible for the care of chronically ill patients. It is now being expanded to other conditions such as chronic kidney disease.

A similar system, The New York City A1C Registry, [20] is in used to monitor the estimated 600,000 diabetic patients in New York City, although unlike the Vermont Diabetes Information System, there are no provisions for patients to have their data excluded from the NYC database. The NYC Department of Health and Mental Hygiene has linked additional patient services to the registry such as health information and improved access to health care services. As of early 2012, the registry contains over 10 million test results on 3.6 million individuals. Although intended to improve health outcomes and reduce the incidence of the complications of diabetes, [21] a formal evaluation has not yet been done.

In May 2008, the City Council of San Antonio, Texas approved the deployment of an A1C registry for Bexar County. Authorized by the Texas Legislature and the state Health Department, the San Antonio Metropolitan Health District [22] implemented the registry which drew results from all the major clinical laboratories in San Antonio. The program was discontinued in 2010 for lack of funds.

Laboratory surveillance differs from population-wide surveillance in that it can only monitor patients who are already receiving medical treatment and therefore having lab tests done. For this reason, it does not identify patients who have never been tested. Therefore, it is more suitable for quality management and care improvement than for epidemiological monitoring of an entire population or catchment area.

See also

Related Research Articles

Influenza vaccine Vaccine against influenza

Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The United States Centers for Disease Control and Prevention (CDC) estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. Immunized workers who do catch the flu, return to work half a day sooner on average. Vaccine effectiveness in those under two years old and those over 65 years old remains uncertain due to a lack of high quality research. Vaccinating children may protect those around them.

Community health is a branch of public health which focuses on people and their role as determinants of their own and other people's health in contrast to environmental health, which focuses on the physical environment and its impact on people's health.

Swine influenza Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any one of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) is any strain of the influenza family of viruses that is endemic in pigs. As of 2009, the known SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

Flu season time period characterized by the prevalence of outbreaks of influenza

Flu season is an annually recurring time period characterized by the prevalence of outbreaks of influenza (flu). The season occurs during the cold half of the year in each hemisphere. Influenza activity can sometimes be predicted and even tracked geographically. While the beginning of major flu activity in each season varies by location, in any specific location these minor epidemics usually take about three weeks to reach its pinnacle, and another 3 weeks to significantly diminish.

Influenza A virus subtype H1N1 Subtype of the influenza A virus

In virology, influenza A virus subtype H1N1 (A/H1N1) is the subtype of Influenza A virus that was the most common cause of human influenza (flu) in 2009, and is associated with the 1918 flu pandemic. It is an orthomyxovirus that contains the glycoproteins haemagglutinin and neuraminidase. For this reason, they are described as H1N1, H1N2 etc. depending on the type of H or N antigens they express with metabolic synergy. Haemagglutinin causes red blood cells to clump together and binds the virus to the infected cell. Neuraminidase is a type of glycoside hydrolase enzyme which helps to move the virus particles through the infected cell and assist in budding from the host cells.

A chronic condition is a human health condition or disease that is persistent or otherwise long-lasting in its effects or a disease that comes with time. The term chronic is often applied when the course of the disease lasts for more than three months. Common chronic diseases include arthritis, asthma, cancer, chronic obstructive pulmonary disease, diabetes and some viral diseases such as hepatitis C and acquired immunodeficiency syndrome. An illness which is lifelong because it ends in death is a terminal illness. It is possible and not unexpected for an illness to change in definition from terminal to chronic. Diabetes and HIV for example were once terminal yet are now considered chronic due to the availability of insulin and daily drug treatment for individuals with HIV which allow these individuals to live while managing symptoms.

Disease surveillance is an epidemiological practice by which the spread of disease is monitored in order to establish patterns of progression. The main role of disease surveillance is to predict, observe, and minimize the harm caused by outbreak, epidemic, and pandemic situations, as well as increase knowledge about which factors contribute to such circumstances. A key part of modern disease surveillance is the practice of disease case reporting.

The Situational Awareness and Preparedness for Public Health Incidences and Reasoning Engines (SAPPHIRE) is a semantics-based health information system capable of tracking and evaluating situations and occurrences that may affect public health. It was developed in 2004 by Dr. Parsa Mirhaji at the University of Texas Health Science Center at Houston using the Semantic Web technologies.

Influenza Infectious disease, "the flu"

Influenza, commonly known as "the flu", is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include: high fever, runny nose, sore throat, muscle and joint pain, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be diarrhea and vomiting, but these are not common in adults. Diarrhea and vomiting occur more commonly in gastroenteritis, which is an unrelated disease and sometimes inaccurately referred to as "stomach flu" or the "24-hour flu". Complications of influenza may include viral pneumonia, secondary bacterial pneumonia, sinus infections, and worsening of previous health problems such as asthma or heart failure.

Influenza-like illness

Influenza-like illness (ILI), also known as flu-like syndrome/symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms.

2009 swine flu pandemic 2009 global H1N1 influenza virus pandemic

The 2009 swine flu pandemic was an influenza pandemic that lasted for about 19 months, from January 2009 to August 2010, and the second of two pandemics involving H1N1 influenza virus. First described in April 2009, the virus appeared to be a new strain of H1N1, which resulted from a previous triple reassortment of bird, swine, and human flu viruses further combined with a Eurasian pig flu virus, leading to the term "swine flu".

Pandemic H1N1/09 virus virus responsible for the 2009 swine flu pandemic

In virology, the pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media. For other names, see the Nomenclature section below.

2009 swine flu pandemic vaccine Vaccine for H1N1 Swine Flu that caused a pandemic in 2009.

The 2009 flu pandemic vaccines were influenza vaccines developed to protect against the pandemic H1N1/09 virus. These vaccines either contained inactivated (killed) influenza virus, or weakened live virus that could not cause influenza. The killed vaccine was injected, while the live vaccine was given as a nasal spray. Both these types of vaccine were produced by growing the virus in chicken eggs. Around three billion doses were produced, with delivery in November 2009.

Influenza prevention involves taking steps that one can use to decrease their chances of contracting flu viruses, such as the Pandemic H1N1/09 virus, responsible for the 2009 flu pandemic.

Infoveillance is a type of syndromic surveillance, which focuses on public health related concerns, that utilizes online information and content. The term was coined by Gunther Eysenbach in 2004 for the first time along with coining, Infodemiology, a new branch of science-based research.

Google Flu Trends Former web service operated by Google

Google Flu Trends (GFT) was a web service operated by Google. It provided estimates of influenza activity for more than 25 countries. By aggregating Google Search queries, it attempted to make accurate predictions about flu activity. This project was first launched in 2008 by Google.org to help predict outbreaks of flu.

Infodemiology, as defined by Gunther Eysenbach, is a new area of science research that focuses on scanning the Internet for user-contributed health-related content, with the ultimate goal of improving public health.

The 2017 Puerto Rico Leptospirosis outbreak was an outbreak of leptospirosis that affected Puerto Rico in the fall of 2017, following Hurricane Maria's landfall.

FluNet is a global web-based tool launched in 1997 and coordinated by the World Health Organization. It is a site for information exchange in the global surveillance of influenza. FluNet contains publically available, real-time global data for influenza virological surveillance. It works as an early-alert system, providing with full access to epidemiological and virological information. FluNet is a collaborative project between the WHO's Division of Emerging and other Communicable Diseases Surveillance and Control, and the French National Institute of Health and Medical Research (Inserm).

The Global Influenza Surveillance and Response System (GISRS) is a global network of laboratories that has for purpose to monitor the spread of influenza with the aim to provide the World Health Organization with influenza control information. It was established in 1952 to conduct global influenza surveillance. GISRS is coordinated by WHO and endorsed by national governments. More than two million respiratory specimens are tested by GISRS annually to monitor the spread and evolution of influenza viruses through a network of about 150 laboratories in 114 countries representing 91% of the world's population. GISRS operates FluNet, an online tool used for virological surveillance of influenza.

References

  1. 1 2 Public health surveillance, World Health Organization (accessed January 14, 2016).
  2. Caves, R. W. (2004). Encyclopedia of the City . Routledge. pp.  548. ISBN   9780415252256.
  3. 1 2 World Health Organization. "Surveillance for Vaccine Preventable Diseases". World Health Organization: Immunization, Vaccines and Biologicals. Retrieved 19 October 2016.
  4. Kilbridge PM, Campbell UC, Cozart HB, Mojarrad MG (Jul–Aug 2006). "Automated Surveillance for Adverse Drug Events at a Community Hospital and an Academic Medical Center". J Am Med Inform Assoc. 13 (4): 372–7. doi:10.1197/jamia.M2069. PMC   1513675 . PMID   16622159.
  5. disa.mil [ dead link ] PDF
  6. "webcitation.org". webcitation.org. Archived from the original on June 24, 2003. Retrieved 2014-04-18.CS1 maint: unfit url (link)
  7. Center for Disease Control, 2004. "Overview of Syndromic Surveillance" Accessed 29 April 2020.
  8. United States Centers for Disease Control and Prevention (WebCited/cached version)
  9. Eysenbach G (2006). "Infodemiology: Tracking Flu-Related Searches on the Web for Syndromic Surveillance". AMIA Annu Symp Proc. 2006: 244–8. PMC   1839505 . PMID   17238340.
  10. "Google Flu Trends". Google.org. Retrieved 2014-04-18.
  11. Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L (2009). "Detecting influenza epidemics using search engine query data". Nature. 457 (7232): 1012–4. Bibcode:2009Natur.457.1012G. doi:10.1038/nature07634. PMID   19020500.
  12. Lampos, Vasileios; Miller, Andrew C.; Crossan, Steve; Stefansen, Christian (3 Aug 2015). "Advances in nowcasting influenza-like illness rates using search query logs". Scientific Reports. 5 (12760): 12760. Bibcode:2015NatSR...512760L. doi:10.1038/srep12760. PMC   4522652 . PMID   26234783.
  13. "Flu Detector – Tracking Epidemics on Twitter". GeoPatterns.enm.bris.ac.uk. Retrieved 2014-04-18.
  14. Lampos V, De Bie T, Cristianini N (2010). Flu Detector – Tracking Epidemics on Twitter. ECML PKDD. pp. 599–602. doi: 10.1007/978-3-642-15939-8_42 .
  15. "vermedx.com". vermedx.com. Archived from the original on 2011-02-02. Retrieved 2014-04-18.
  16. MacLean, Charles D.; Littenberg, Benjamin; Gagnon, Michael (1970-01-01). "MacLean CD, Littenberg B, Gagnon M. Diabetes Decision Support: Initial Experience with the Vermont Diabetes Information System in Community Primary Care. Am J Pub Health 2006; 96:593–595". American Journal of Public Health. Ajph.org. 96 (4): 593–595. doi:10.2105/AJPH.2005.065391. PMC   1470550 . PMID   16507723.
  17. Littenberg, B; MacLean, CD; Zygarowski, K; Drapola, BH; Duncan, JA; Frank, CR (Mar 2009). "The Vermedx Diabetes Information System reduces healthcare utilization". The American Journal of Managed Care. 15 (3): 166–70. PMID   19298097.
  18. Maclean, CD; Gagnon, M; Callas, P; Littenberg, B (Dec 2009). "The Vermont diabetes information system: a cluster randomized trial of a population based decision support system". Journal of General Internal Medicine. 24 (12): 1303–10. doi:10.1007/s11606-009-1147-x. PMC   2787948 . PMID   19862578.
  19. Khan, S; Maclean, CD; Littenberg, B (Jul 2010). "The effect of the Vermont Diabetes Information System on inpatient and emergency room use: results from a randomized trial". Health Outcomes Research in Medicine. 1 (1): e61–e66. doi:10.1016/j.ehrm.2010.03.002. PMC   2958673 . PMID   20975923.
  20. Archived June 9, 2007, at the Wayback Machine
  21. Frieden, Thomas R. (1970-01-01). "Frieden, Thomas R; "Letter: New York City's Diabetes Reporting System Helps Patients and their Physicians"; American Journal of Public Health; July 16, 2006". American Journal of Public Health. Ajph.aphapublications.org. 98 (9): 1543–1544. doi:10.2105/AJPH.2008.142026. PMC   2509589 . PMID   18633070.
  22. "Metropolitan Health District". Sanantonio.gov. Retrieved 2014-04-18.